HomeCancerLeukemia

Leukemia

Leukemia

Famend Leukemia Researcher & Clinician Joins NYU Langone Well being’s Perlmutter Most cancers Middle as New Chief Scientific Officer

Editor -
NYU Langone Well being’s Perlmutter Most cancers Middle has named Jonathan M. Gerber, MD, as its new chief medical officer. Dr. Gerber joins...
Leukemia

Cellectis Features FDA Designations for Leukemia Remedy

Editor -
Cellectis SA (CLLS) has launched an replace. Cellectis SA’s UCART22, a gene-edited CAR T-cell product candidate, has acquired Orphan Drug and Uncommon Pediatric Illness...
Leukemia

FDA Grants Orphan Drug and Uncommon Pediatric Illness

Editor -
ALL represents 10% of all leukemia instances in america, progresses quickly, and is usually deadly inside weeks or months if left untreated1There's an...
Leukemia

Cellectis’ UCART22 Granted ODD And RPDD Standing By FDA

Editor -
The U.S. Meals and Drug Administration (FDA) has granted Orphan Drug (ODD) and Uncommon Pediatric Illness Designation...
Leukemia

Potential Trials Wanted on Use of Procedural Sedation in Kids With B-ALL

Editor -
There must be better consistency and steering...
1...111213...80Page 12 of 80

Hot Topics

Load more

Quick Links

Must Read

Popular Articles

© 2024 Cancer Care Portal. All rights reserved.